Skip to main content
Top
Published in: Clinical Orthopaedics and Related Research® 10/2013

01-10-2013 | Symposium: 2012 Musculoskeletal Infection Society

What is the Rate of Methicillin-resistant Staphylococcus aureus and Gram-negative Infections in Open Fractures?

Authors: Antonia F. Chen, MD, MBA, Verena M. Schreiber, MD, Wesley Washington, Nalini Rao, MD, Andrew R. Evans, MD

Published in: Clinical Orthopaedics and Related Research® | Issue 10/2013

Login to get access

Abstract

Background

There have been increasing reports of methicillin-resistant Staphylococcus aureus (MRSA) infections in the community, but it is unclear whether infectious organisms in open fracture infections have changed and if our current regimen of antibiotic prophylaxis is therefore obsolete.

Questions/Purposes

We determined the recent incidence of MRSA and Gram-negative organism infections after open fractures.

Methods

We performed a retrospective cohort study on 189 patients with 202 open fractures treated from 2009 to 2010. During the followup, patients were evaluated for signs of infection using the Centers for Disease Control and Prevention criteria. We determined the organisms using routine microbiology culture. The minimum followup was 3 months (median, 47 months; range, 3–108 months).

Results

Of the 202 open fractures, 20 (10%) developed infections. The most common organism was Staphylococcus, whereas five (25%) of those infected were positive for MRSA, and 11 (55%) of those with infection were cultured for at least one Gram-negative organism. Six (30%) open fractures had infections that grew out multiple organisms. The incidence of MRSA infections in our open fracture population was 2.5%.

Conclusions

There is a high incidence of MRSA and Gram-negative infections after open fractures, which may indicate that current antibiotic regimens need to be changed.

Level of Evidence

Level IV, retrospective case-series. See the Guidelines for Authors for a complete description of levels of evidence.
Literature
1.
go back to reference Awad SS, Elhabash SI, Lee L, Farrow B, Berger DH. Increasing incidence of methicillin-resistant Staphylococcus aureus skin and soft-tissue infections: reconsideration of empiric antimicrobial therapy. Am J Surg. 2007;194:606–610.PubMedCrossRef Awad SS, Elhabash SI, Lee L, Farrow B, Berger DH. Increasing incidence of methicillin-resistant Staphylococcus aureus skin and soft-tissue infections: reconsideration of empiric antimicrobial therapy. Am J Surg. 2007;194:606–610.PubMedCrossRef
2.
go back to reference Calfee DP. Methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci, and other Gram-positives in healthcare. Curr Opin Infect Dis. 2012;25:385–394.PubMedCrossRef Calfee DP. Methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci, and other Gram-positives in healthcare. Curr Opin Infect Dis. 2012;25:385–394.PubMedCrossRef
3.
go back to reference Carsenti-Etesse H, Doyon F, Desplaces N, Gagey O, Tancrede C, Pradier C, Dunais B, Dellamonica P. Epidemiology of bacterial infection during management of open leg fractures. Eur J Clin Microbiol Infect Dis. 1999;18:315–323.PubMedCrossRef Carsenti-Etesse H, Doyon F, Desplaces N, Gagey O, Tancrede C, Pradier C, Dunais B, Dellamonica P. Epidemiology of bacterial infection during management of open leg fractures. Eur J Clin Microbiol Infect Dis. 1999;18:315–323.PubMedCrossRef
4.
go back to reference Dellinger EP, Caplan ES, Weaver LD, Wertz MJ, Droppert BM, Hoyt N, Brumback R, Burgess A, Poka A, Benirschke SK, et al. Duration of preventive antibiotic administration for open extremity fractures. Arch Surg. 1988;123:333–339.PubMedCrossRef Dellinger EP, Caplan ES, Weaver LD, Wertz MJ, Droppert BM, Hoyt N, Brumback R, Burgess A, Poka A, Benirschke SK, et al. Duration of preventive antibiotic administration for open extremity fractures. Arch Surg. 1988;123:333–339.PubMedCrossRef
5.
go back to reference Dellinger EP, Miller SD, Wertz MJ, Grypma M, Droppert B, Anderson PA. Risk of infection after open fracture of the arm or leg. Arch Surg. 1988;123:1320–1327.PubMedCrossRef Dellinger EP, Miller SD, Wertz MJ, Grypma M, Droppert B, Anderson PA. Risk of infection after open fracture of the arm or leg. Arch Surg. 1988;123:1320–1327.PubMedCrossRef
6.
go back to reference Garner JS, Jarvis WR, Emori TG, Horan TC, Hughes JM. CDC definitions for nosocomial infections, 1988. Am J Infect Control. 1988;16:128–140.PubMedCrossRef Garner JS, Jarvis WR, Emori TG, Horan TC, Hughes JM. CDC definitions for nosocomial infections, 1988. Am J Infect Control. 1988;16:128–140.PubMedCrossRef
7.
go back to reference Glass GE, Barrett SP, Sanderson F, Pearse MF, Nanchahal J. The microbiological basis for a revised antibiotic regimen in high-energy tibial fractures: preventing deep infections by nosocomial organisms. J Plast Reconstr Aesthet Surg. 2011;64:375–380.PubMedCrossRef Glass GE, Barrett SP, Sanderson F, Pearse MF, Nanchahal J. The microbiological basis for a revised antibiotic regimen in high-energy tibial fractures: preventing deep infections by nosocomial organisms. J Plast Reconstr Aesthet Surg. 2011;64:375–380.PubMedCrossRef
8.
go back to reference Gustilo R, Merkow R, Templeman D. Current concepts review: the management of open fractures. J Bone Joint Surg Am. 1990;72:299–304.PubMed Gustilo R, Merkow R, Templeman D. Current concepts review: the management of open fractures. J Bone Joint Surg Am. 1990;72:299–304.PubMed
9.
go back to reference Gustilo RB, Anderson JT. Prevention of infection in the treatment of one thousand and twenty-five open fractures of long bones: retrospective and prospective analyses. J Bone Joint Surg Am. 1976;58:453–458.PubMed Gustilo RB, Anderson JT. Prevention of infection in the treatment of one thousand and twenty-five open fractures of long bones: retrospective and prospective analyses. J Bone Joint Surg Am. 1976;58:453–458.PubMed
10.
go back to reference Gustilo RB, Gruninger RP, Davis T. Classification of type III (severe) open fractures relative to treatment and results. Orthopedics. 1987;10:1781–1788.PubMed Gustilo RB, Gruninger RP, Davis T. Classification of type III (severe) open fractures relative to treatment and results. Orthopedics. 1987;10:1781–1788.PubMed
11.
go back to reference Gustilo RB, Mendoza RM, Williams DN. Problems in the management of type III (severe) open fractures: a new classification of type III open fractures. J Trauma. 1984;24:742–746.PubMedCrossRef Gustilo RB, Mendoza RM, Williams DN. Problems in the management of type III (severe) open fractures: a new classification of type III open fractures. J Trauma. 1984;24:742–746.PubMedCrossRef
12.
go back to reference Johnson EN, Burns TC, Hayda RA, Hospenthal DR, Murray CK. Infectious complications of open type III tibial fractures among combat casualties. Clin Infect Dis. 2007;45:409–415.PubMedCrossRef Johnson EN, Burns TC, Hayda RA, Hospenthal DR, Murray CK. Infectious complications of open type III tibial fractures among combat casualties. Clin Infect Dis. 2007;45:409–415.PubMedCrossRef
13.
go back to reference Johnson KD, Johnston DW. Orthopedic experience with methicillin-resistant Staphylococcus aureus during a hospital epidemic. Clin Orthop Relat Res. 1986;212:281–288.PubMed Johnson KD, Johnston DW. Orthopedic experience with methicillin-resistant Staphylococcus aureus during a hospital epidemic. Clin Orthop Relat Res. 1986;212:281–288.PubMed
14.
go back to reference Jorgenson MR, DePestel DD, Carver PL. Ceftaroline fosamil: a novel broad-spectrum cephalosporin with activity against methicillin-resistant Staphylococcus aureus. Ann Pharmacother. 2011;45:1384–1398.PubMedCrossRef Jorgenson MR, DePestel DD, Carver PL. Ceftaroline fosamil: a novel broad-spectrum cephalosporin with activity against methicillin-resistant Staphylococcus aureus. Ann Pharmacother. 2011;45:1384–1398.PubMedCrossRef
15.
go back to reference Mackenzie EJ, Rivara FP, Jurkovich GJ, Nathens AB, Egleston BL, Salkever DS, Frey KP, Scharfstein DO. The impact of trauma-center care on functional outcomes following major lower-limb trauma. J Bone Joint Surg Am. 2008;90:101–109.PubMedCrossRef Mackenzie EJ, Rivara FP, Jurkovich GJ, Nathens AB, Egleston BL, Salkever DS, Frey KP, Scharfstein DO. The impact of trauma-center care on functional outcomes following major lower-limb trauma. J Bone Joint Surg Am. 2008;90:101–109.PubMedCrossRef
16.
go back to reference Ong CT, Choon DS, Cabrera NP, Maffulli N. The treatment of open tibial fractures and of tibial non-union with a novel external fixator. Injury. 2002;33:829–834.PubMedCrossRef Ong CT, Choon DS, Cabrera NP, Maffulli N. The treatment of open tibial fractures and of tibial non-union with a novel external fixator. Injury. 2002;33:829–834.PubMedCrossRef
17.
go back to reference Patzakis MJ, Harvey JP Jr, Ivler D. The role of antibiotics in the management of open fractures. J Bone Joint Surg Am. 1974;56:532–541.PubMed Patzakis MJ, Harvey JP Jr, Ivler D. The role of antibiotics in the management of open fractures. J Bone Joint Surg Am. 1974;56:532–541.PubMed
18.
go back to reference Patzakis MJ, Wilkins J, Moore TM. Considerations in reducing the infection rate in open tibial fractures. Clin Orthop Relat Res. 1983;178:36–41.PubMed Patzakis MJ, Wilkins J, Moore TM. Considerations in reducing the infection rate in open tibial fractures. Clin Orthop Relat Res. 1983;178:36–41.PubMed
19.
go back to reference Poon H, Chang MH, Fung HB. Ceftaroline fosamil: a cephalosporin with activity against methicillin-resistant Staphylococcus aureus. Clin Ther. 2012;34:743–765.PubMedCrossRef Poon H, Chang MH, Fung HB. Ceftaroline fosamil: a cephalosporin with activity against methicillin-resistant Staphylococcus aureus. Clin Ther. 2012;34:743–765.PubMedCrossRef
20.
go back to reference Ray GT, Suaya JA, Baxter R. Trends and characteristics of culture-confirmed Staphylococcus aureus infections in a large US integrated health care organization. J Clin Microbiol. 2012;50:1950–1957.PubMedCrossRef Ray GT, Suaya JA, Baxter R. Trends and characteristics of culture-confirmed Staphylococcus aureus infections in a large US integrated health care organization. J Clin Microbiol. 2012;50:1950–1957.PubMedCrossRef
21.
go back to reference Rittmann WW, Schibli M, Matter P, Allgower M. Open fractures. Long-term results in 200 consecutive cases. Clin Orthop Relat Res. 1979;138:132–140.PubMed Rittmann WW, Schibli M, Matter P, Allgower M. Open fractures. Long-term results in 200 consecutive cases. Clin Orthop Relat Res. 1979;138:132–140.PubMed
22.
go back to reference Saveli CC, Belknap RW, Morgan SJ, Price CS. The role of prophylactic antibiotics in open fractures in an era of community-acquired methicillin-resistant Staphylococcus aureus. Orthopedics. 2011;34:611–616; quiz 617. Saveli CC, Belknap RW, Morgan SJ, Price CS. The role of prophylactic antibiotics in open fractures in an era of community-acquired methicillin-resistant Staphylococcus aureus. Orthopedics. 2011;34:611–616; quiz 617.
23.
go back to reference Yokoyama K, Itoman M, Shindo M, Kai H. Contributing factors influencing type III open tibial fractures. J Trauma. 1995;38:788–793.PubMedCrossRef Yokoyama K, Itoman M, Shindo M, Kai H. Contributing factors influencing type III open tibial fractures. J Trauma. 1995;38:788–793.PubMedCrossRef
Metadata
Title
What is the Rate of Methicillin-resistant Staphylococcus aureus and Gram-negative Infections in Open Fractures?
Authors
Antonia F. Chen, MD, MBA
Verena M. Schreiber, MD
Wesley Washington
Nalini Rao, MD
Andrew R. Evans, MD
Publication date
01-10-2013
Publisher
Springer US
Published in
Clinical Orthopaedics and Related Research® / Issue 10/2013
Print ISSN: 0009-921X
Electronic ISSN: 1528-1132
DOI
https://doi.org/10.1007/s11999-013-2855-4

Other articles of this Issue 10/2013

Clinical Orthopaedics and Related Research® 10/2013 Go to the issue